Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis (CONCERTO)

NCT06978660 is registered in ClinicalTrials.gov with Idoven 1903 S.L. as lead sponsor.

NCT NCT06978660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06978660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis (CONCERTO)
Lead sponsor
Idoven 1903 S.L.
Phase
Observational
Overall status
Recruiting
Start date
May 27, 2025
Completion date
December 31, 2026
Enrollment
2,200 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin cardiac amyloidosis